glp 1 pharmaceuticals Life after weight-loss drugs GLP-1 Drugs in India: Growing

As an experimental peptide , users accept a certain degree of risk and should let their provider know if they experience any adverse reactions

The average weight loss decreased to 7.5 lb., according to results extending beyond 12 months

In the GLP-1 RA group, 133 participants were hospitalised (mean number of hospitalisations=9, median number of hospitalisations=3) over a 5-year period with a mean and median length of stay of 6 and 2 days, respectively

Rathkopf DP, Choudhury MR, Rasco AD, Lakhani D, Hawley N, Srinivas JE, et al

Some of the alleged injuries include gastrointestinal conditions, pancreatic diseases, gallbladder issues, and blood clots